Corsi Di Formazione Organizzati Da MSO - ANNO 2018

CORSO: Cancer Translational Research: from molecular biology to the real world setting
Chieti, 20 April 2018

Direttore: Clara Natoli
CREDITI ECM: 6

SCARICA IL PDF...

PROGRAMMA DEL CORSO (CLICCARE SULLE ICONE PER SCARICARE LE SLIDES)
09:00 Registration & Welcome coffee
09:30 Welcome from
Luigi Capasso - Presidente Fondazione Università Gabriele D'Annunzio
Agostino Consoli - Direttore CESI-MeT
Patrizia Di Iorio - Presidente Scuola di Medicina e Scienze della Salute - Chieti
SESSION I
Moderatori: Roberta di Pietro, Alessandro Cama
09:50 The canine model in the cancer fight: role of comparative oncology in translational research Mariarita Romanucci, Leonardo Della Salda
10:10 Telomeric activities of the PML protein in normal and neoplastic cells Francesco Grignani
10:20 Sarcomas: a model for translational medicine Massimo Aglietta
10:40 General discussion
Session II
Moderatori: Marina Scarpelli, Antonio Marchetti
10:50 The present and future of biomarkers in prostate cancer: proteomics and genomics Arcangelo Sebastianelli, Marco Carini
11:10 Asbestost and intrahepatic cholangiocarcinoma: from epidemiology to NGS Giovanni Brandi
11:30 New potentials for liquid biopsies in oncology Marta Castiglia, Antonio Russo
11:50 General discussion
12:10 Coffee break
Session III
Felice Mucilli, Domenico Genovesi
12:30 The world of the EGF-Receptor: focus on lung cancer Roberto Bianco
12:50 First line treatment of metastatic colorectal cancer: from RCT to clinical practice Nicola Tinari, Clara Natoli
13:10 General discussion
13:30 Light lunch
Session IV
Moderatori: Adriano Piattelli, Raffaella Muraro
14:30 New therapies in oncology: focus on oral complications Lorenzo Lo Muzio
14:50 General discussion
Session V
Moderatori: Ettore Cianchetti, Corrado Ficorella
15:10 PAM50 in breast cancer Giuseppe Tonini
15:30 Luminal Metastatic Breast Cancer: role of CDK4/6 inhibitors from preclinical data to clinical practice Vincenzo Adamo
15:50 Highlights on triple positive breast cancer Patrizia Querzoli
16:10 HER2+ breast cancer: from RCT to the real world scenario Antonino Grassadonia, Clara Natoli
16:30 General discussion
16:40 Coffee break
Session VI
Moderatori: Liborio Stuppia, Clara Natoli
17:00 BRCA1 and BRCA2 mutations in breast or ovarian cancer probands at risk of genetic predisposition Tina Sidoni, Corrado Ficorella
17:20 PARP Inhibitors in breast cancer treatment Silverio Tomao
17:40 General discussion
18:00 Take-home messages and conclusions Clara Natoli